Table 3.
Wilcoxon signed-rank test for before and after measurements in the treatment group.
| Characteristic | N 1 | Initial Value 2 | Final Value | p-Value |
|---|---|---|---|---|
| Cholesterol (mg/dL) 3 | 59 | 193 (154, 216) | 190 (154, 234) | 0.803 |
| AC (cm) 3 | 58 | 118 (111, 126) | 118 (109 126) | 0.081 |
| Triglycerides (mg/dL) 3 | 59 | 168 (126, 232) | 177 (119, 235) | 0.966 |
| BMI (kg/m2) 3 | 58 | 35.0 (31.4, 40.6) | 34.0 (30.6, 39.8) | <0.001 |
| CAP (dB/m) 3 | 21 | 359 (323, 384) | 342 (290, 376) | 0.037 |
| TE (kPa) 3 | 21 | 7.2 (5.9, 9.9) | 6.2 (5.3, 9.7) | 0.079 |
1 Number of measurements (end vs. start of intervention). 2 Median values (Q1, Q3) are presented for each group. 3 Change from baseline. AC—abdominal circumference, BMI—body mass index, CAP—controlled attenuation parameter, and TE—transient elastography.